GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sichuan Kelun Pharmaceutical Co Ltd (SZSE:002422) » Definitions » Equity-to-Asset

Sichuan Kelun Pharmaceutical Co (SZSE:002422) Equity-to-Asset : 0.59 (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Sichuan Kelun Pharmaceutical Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Sichuan Kelun Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥22,260 Mil. Sichuan Kelun Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2024 was ¥37,676 Mil. Therefore, Sichuan Kelun Pharmaceutical Co's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.59.

The historical rank and industry rank for Sichuan Kelun Pharmaceutical Co's Equity-to-Asset or its related term are showing as below:

SZSE:002422' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.4   Med: 0.45   Max: 0.59
Current: 0.59

During the past 13 years, the highest Equity to Asset Ratio of Sichuan Kelun Pharmaceutical Co was 0.59. The lowest was 0.40. And the median was 0.45.

SZSE:002422's Equity-to-Asset is ranked better than
52.39% of 1086 companies
in the Drug Manufacturers industry
Industry Median: 0.58 vs SZSE:002422: 0.59

Sichuan Kelun Pharmaceutical Co Equity-to-Asset Historical Data

The historical data trend for Sichuan Kelun Pharmaceutical Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sichuan Kelun Pharmaceutical Co Equity-to-Asset Chart

Sichuan Kelun Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.42 0.42 0.44 0.46 0.54

Sichuan Kelun Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 0.47 0.53 0.54 0.59

Competitive Comparison of Sichuan Kelun Pharmaceutical Co's Equity-to-Asset

For the Drug Manufacturers - General subindustry, Sichuan Kelun Pharmaceutical Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sichuan Kelun Pharmaceutical Co's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sichuan Kelun Pharmaceutical Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Sichuan Kelun Pharmaceutical Co's Equity-to-Asset falls into.



Sichuan Kelun Pharmaceutical Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Sichuan Kelun Pharmaceutical Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=19672.378/36454.901
=0.54

Sichuan Kelun Pharmaceutical Co's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=22260.402/37676.458
=0.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sichuan Kelun Pharmaceutical Co  (SZSE:002422) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Sichuan Kelun Pharmaceutical Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Sichuan Kelun Pharmaceutical Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Sichuan Kelun Pharmaceutical Co (SZSE:002422) Business Description

Traded in Other Exchanges
N/A
Address
No.36 West Baihua Road, Qingyang District, Chengdu, CHN, 610071
Sichuan Kelun Pharmaceutical Co Ltd is a China-based Pharmaceutical company mainly focused on the production and sales of injection products, including products for glucose injection and sodium chloride injection. It manufactures and sells high-volume injections (infusions), small-volume injections (water needles), sterile powder injections (containing powdered and freeze-dried powder). Its products include tablets, capsules, capsules, granules, oral liquids, peritoneal dialysis fluids, raw material medicines, medical packaging materials, medical instruments, and antibiotic intermediates.
Executives
Lai De Gui Executives
Feng Hao Directors, executives
Liu Si Chuan Directors, executives
Wang Jing Yi Directors, executives
Wan Yang Yu Executives
Ge Jun You Executives
Wu Zhong Hua Executives
Wan Peng Supervisors
Tan Hong Bo Executives
Liu Ge Xin Director
Huang Xin Securities Affairs Representative
Ge Tao Executives
Pan Hui Directors, executives
Zhou Xiao Dong Executives
Zheng Chang Yan Supervisors

Sichuan Kelun Pharmaceutical Co (SZSE:002422) Headlines

No Headlines